Endeavor

Moffitt Experts’ Study Aims to Improve TIL Therapy Process

Tumor-infiltrating lymphocyte therapy is FDA approved to treat melanoma.

TIL Therapy for Advanced Melanoma Offers Promising Results

The study shows 36% of patients experienced a positive response to the therapy

AI Helps Predict Treatment Response in Melanoma

Identifying and analyzing immune cells under the microscope can help personalize therapies

Oral Drug Shows Potential for Advanced Melanoma Treatment

HBI-8000 combined with nivolumab shows promise in a phase 2 trial at Moffitt

How Has President Jimmy Carter Survived Brain Cancer for 9 Years?

Moffitt experts explain how immunotherapy treatment is increasing survival for melanoma brain metastases

New Study May Help Refine Sentinel Node Biopsy Decisions for Melanoma Patients

Utilizing a gene expression test could help surgeons and patients decide whether sentinel node biopsy surgery is the right approach

No Surprise Here: TikTok Sunburning Trend has Plenty of Problems

Experts warn there is no such thing as a healthy tan or sunburn

Moffitt Welcomes Pint-Size Patients for Pediatric Melanoma Clinic Day

The annual event welcomes younger patients with activities, treats and therapy dogs

Nearly Half of Cancer Deaths in US Linked to Modifiable Risk Factors

Smoking, obesity and alcohol consumption among biggest culprits